Pulmatrix Inc.

Industry · 15 registered clinical trials.

Status	Trial	Phase	Started
Terminated	Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA ABPA	Phase 2	2023-02-01
Completed	A Study to Assess the Safety, Tolerability, and Pharmacokinetics of PUR3100 in Health Adults Healthy	Phase 1	2022-06-09
Completed	A Phase 1b Study of PUR1800 in Patients With COPD Chronic Obstructive Pulmonary Disease (COPD)	Phase 1	2021-01-04
Terminated	Study in Adult Asthmatic Patients With Allergic Bronchopulmonary Aspergillosis Allergic Bronchopulmonary Aspergillosis	Phase 2	2019-07-31
Completed	Safety, Tolerability and Pharmacokinetics of PUR1900 (Itraconazole Powder) in Healthy Volunteers and Adults Wi Asthma	Phase 1	2018-02-09
Completed	A PK Study to Evaluate PUR0200 and a Reference Product in Healthy Subjects Healthy	Phase 1	2016-01-01
Terminated	A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60 Postoperative Wound Infection-deep, Post Operative Wound Infection	Phase 1 / Phase 2	2014-10-01
Completed	21 Day Cumulative Skin Irritation of RUT058-60 Irritation/Irritant	Phase 1	2014-07-01
Completed	A Safety, Pharmacokinetic and Pharmacodynamic Study of PUR0200 in COPD Patients Chronic Obstructive Pulmonary Disease (COPD)	Phase 1	2013-07-01
Completed	Evaluation of the Effect of PUR118 on Ozone Induced Airway Inflammation in Healthy Normal Volunteers Chronic Obstructive Pulmonary Disease (COPD)	Phase 1	2012-08-01
Completed	A Safety and Tolerability Study OF PUR118 In Subjects With Cystic Fibrosis Cystic Fibrosis	Phase 1	2012-02-01
Completed	Safety, Tolerability, and Pharmacodynamic Effect Study of PUR118 Chronic Obstructive Pulmonary Disease	Phase 1	2011-02-01
Completed	Determination of the in Vitro Effects of Cationic Airway Lining Modulators (CALM) on Chronic Obstructive Pulmo Chronic Obstructive Pulmonary Disease	—	2010-04-01
Completed	Effect of PUR003 on Asthma Asthma, Lung Diseases, Bronchial Diseases	Phase 1	2009-12-01
Completed	Safety and Efficacy Study of Inhaled PUR003 on a Controlled Influenza Virus Challenge in Healthy Adult Subject Healthy	Phase 1	2009-07-01